Clinical Trial Update: Botulinum Toxin Versus Platelet Rich Fibrin for TMJ Internal Derangement [NA]

View source ↗

Summary

A completed clinical trial comparing botulinum toxin versus platelet-rich fibrin for temporomandibular joint internal derangement.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Temporomandibular Joint Disorders
• Temporomandibular Joint Internal Derangement

Drugs mentioned

• Botulinum toxin (botulinum toxin)
• Platelet Rich Fibrin (platelet-rich fibrin)

Snippet

Sponsor: Suez Canal University | Conditions: Temporomandibular Joint Internal Derangement, Temporomandibular Joint Disorders | NA | Status: COMPLETED